Gni Group Ltd. (2160) Press Release
Promotion of Proprietary Brand Business in the Medtech Segment
Earlier from Gni
- Notice Regarding Change in Major Shareholder
- Q2 FY2026 Financial Results Corporate Presentation
- Consolidated Financial Results for Q2 FY2026 (IFRS)
- Notice Concerning the Completion of the Acquisition of All Shares of AYUMI Pharmaceutical Holdings KK (Conversion into a Wholly-Owned Subsidiary)
